Rubicon Research

Not Rated
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE506V01022
  • NSEID: RUBICON
  • BSEID: 544578
INR
635.80
11.5 (1.84%)
BSENSE

Dec 05

BSE+NSE Vol: 6.05 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Rubicon Research Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
194.00
102.00
-11.00
-66.00
63.00
74.00
Adjustment
93.00
71.00
46.00
27.00
36.00
28.00
Changes In working Capital
-90.00
-135.00
-108.00
-15.00
-4.00
-70.00
Cash Flow after changes in Working Capital
197.00
39.00
-72.00
-54.00
95.00
32.00
Cash Flow from Operating Activities
159.00
21.00
-74.00
-62.00
61.00
5.00
Cash Flow from Investing Activities
-65.00
-68.00
-32.00
-45.00
-46.00
-84.00
Cash Flow from Financing Activities
-39.00
43.00
122.00
63.00
51.00
80.00
Net Cash Inflow / Outflow
54.00
-3.00
15.00
-45.00
67.00
1.00
Opening Cash & Cash Equivalents
50.00
54.00
38.00
84.00
10.00
9.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
104.00
50.00
54.00
38.00
77.00
10.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Rubicon Research
Markets Mojo
Figures in Cr
standaloned Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
223.28
246.8
-23.00
-9.53%
Adjustment
68.35
0.5
68.00
13570.00%
Changes In working Capital
-235.12
316.1
-551.00
-174.38%
Cash Flow after changes in Working Capital
56.51
563.4
-507.00
-89.97%
Cash Flow from Operating Activities
29.65
439
-410.00
-93.25%
Cash Flow from Investing Activities
-10.22
1.9
-11.00
-637.89%
Cash Flow from Financing Activities
-34.05
-115.6
81.00
70.54%
Net Cash Inflow / Outflow
-14.62
325.3
-339.00
-104.49%
Opening Cash & Cash Equivalents
40.47
1.6
39.00
2429.37%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
25.85
326.9
-301.00
-92.09%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is 657.64% vs 128.11% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
159.18
21.01
657.64%